Alphatec Corp (ATEC) Enterprise Value to EBITDA Ratio
Analyzing the EV/EBITDA valuation dynamics on GURU.Markets, it is evident that the value is fixed at 28.03. Alphatec Holdings, Inc. (ATEC) has earned a reputation as a bold innovator, gaining the genuine trust of surgeons. The brand is implementing AI platforms and robotics for precision planning of spinal surgeries. Simultaneously, the company is reducing its carbon footprint by optimizing sterile logistics and phasing out toxic plastics.
Comprehensive metric breakdowns and analytics for atecspine.com (ATEC)
- current price and projected stock value:
- market capitalization details:
- business book valuation details:
- debt burden and liquidity indicators:
- financial results and valuation multiples details:
ATEC - Net Financial Result|Projected Future Earnings Alphatec Holdings, Inc.|ATEC - Price to Earnings Ratio|Forward P/E Multiple Alphatec Holdings, Inc.|ATEC - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Alphatec Corp|ATEC - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Alphatec|ATEC - Earnings per share for the trailing year|Quarterly EPS earnings growth atecspine.com|ATEC - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Alphatec Holdings, Inc.
- revenue and sales details:
Analysis of all company metrics:ATEC Spine ATEC
The EV/EBITDA multiple determines the total business value relative to operating profit, accounting for debt load and tax obligations to assess the real value of assets. By analyzing the EV/EBITDA ratio of Alphatec Holdings, Inc. (ATEC) on the chart, an investor can see the balance between the market price and the ability of Alphatec Holdings, Inc. (ATEC) to act as a cash generator, which is critical given constant R&D expenditures and moderately stable flows from surgical equipment sales.
Competitor analysis
EV/EBITDA Multiple BSX (Boston Scientific Inc)|Total Company Value to Operating Income Before Depreciation Ratio Edwards Lifesciences Inc. (EW)|RMD: Enterprise Value to EBITDA Ratio|Company Value to Operating Income Before Depreciation Ratio PODD|ZBH: EV/EBITDA Multiple|Company Value to EBITDA The Cooper Companies, Inc. (COO)|ALGN (Align Technology Inc) - EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation GMED (NuVasive)|Enterprise Value to EBITDA Ratio TMDX (TransMedics)|AORT (artivion.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Enovis ENOV|IART - Enterprise Value to EBITDA Ratio|Motiva - EV/EBITDA Multiple|Company Value to EBITDA iLet Bionic Pancreas|IRMD: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation EMBC|TNDM (Tandem Diabetes Care, Inc.) - EV/EBITDA Multiple|AxoGen Inc (AXGN) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple SIBN|Enterprise Value to EBITDA Ratio Orthofix Corp OFIX|EV/EBITDA Multiple BVS (Bioventus Inc.)|EV/EBITDA Multiple OrthoPediatrics Corp KIDS|TMCI - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SRTA: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|CARL (Carlsmed Corp) - Enterprise Value to EBITDA Ratio|RxSight Ophthalmic - Business Value to Operating Income Before Depreciation|CLPT (ClearPoint Neuro Inc.) - EV/EBITDA Multiple|Company Value to EBITDA stereotaxis.com STXS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Neuronetics (STIM)|Sight Sciences Inc. (SGHT) - Enterprise Value to EBITDA Multiple|Orchestra BioMed - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Anika Therapeutics Inc. ANIK|InspireMD, Inc. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Jin Medical International ZJYL|vivani.com (VANI) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio XTNT (Xtant Medical)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization NeuroOne Corp|Enterprise Value to EBITDA Ratio Modular Med (MODD)|EV/EBITDA Multiple MYO|COCH - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Vivos Therapeutics, Inc. VVOS|NVNO: Enterprise Value to Operating Income Before Depreciation|SINT: Enterprise Value to EBITDA Ratio|Tenon Medical Inc - Enterprise Value to Operating Income Before Depreciation Ratio|LFWD: EV/EBITDA Multiple|Autonomix Medical (AMIX) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization INVO Fertility|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization BBLG|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Axonics Modulation Technologies (AXNX)|BIOL: Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple DYNT (Dynatronics)|Business Value to Operating Income Before Depreciation FNA|INVO Bio - EV/EBITDA Multiple
